Clinical Trial

Stavanger University Hospital Inflammatory Bowel Disease Trial

Study acronym: SUSI
Recruiting
View on ClinicalTrials.gov →
Summary
The study aims at studying the outcomes of a protocol-based handling of newly diagnosed Inflammatory bowel disease ( IBD ) patients within a defined uptake area in Norway. It is a descriptive study and no hypothesis is predefined. Cytokine studies, QoL and fatigue assessment will be included for hypothesis-generating purposes.
Protocol Amendment History 8 amendments
This ClinicalTrials.gov record has been amended 8 times since 2012-03-09; most recent amendment 2025-05-13.
Status change: Not Yet Recruiting → Recruiting 2013-12-04
Trial Details
NCT Number NCT01551563
Lead Sponsor Helse Stavanger HF
Conditions IBD
Enrollment 700 participants
Start Date 2012-04
Primary Completion 2026-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-05-16